The GLP-1 drugs are strong auto-immune regulators and neuroprotective and show promise with related disease: https://www.mdpi.com/1422-0067/26/6/2741 https://w

The GLP-1 drugs are strong auto-immune regulators and neuroprotective and show promise with related disease: https://www.mdpi.com/1422-0067/26/6/2741 https://www.mdpi.com/1422-0067/26/6/2741 https://aaic.alz.org/releases-2024/glp-drug-liraglutide-may-protect-against-dementia.asp https://aaic.alz.org/releases-2024/glp-drug-liraglutide-may-... https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14313 https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz... https://pmc.ncbi.nlm.nih.gov/articles/PMC11242057/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11242057/ Some promise for autism and depression, though little with schizophrenia: https://www.psychiatrist.com/pcc/efficacy-glp-1-agonists-psychiatric-illnesses-scoping-review/ https://www.psychiatrist.com/pcc/efficacy-glp-1-agonists-psy... https://www.news-medical.net/news/20250511/GLP-1-receptor-agonists-improve-mood-and-metabolic-health-in-adults-with-mental-illness.aspx https://www.news-medical.net/news/20250511/GLP-1-receptor-ag...